Plain-English translation of ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study follows women with advanced ovarian cancer who are being treated with PARP inhibitors—a type of medication that helps prevent cancer cells from repairing themselves. Researchers will collect blood and bone marrow samples before you start the medication and during your treatment to carefully monitor how the medication affects your blood cells and bone marrow over time.
While this medication works well against ovarian cancer, doctors want to better understand its long-term effects on the blood-forming cells in your bone marrow. In rare cases, some cancer treatments can lead to changes in blood cell production, so this study aims to detect and understand these changes early if they occur.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn and possibly a bone marrow sample taken (a procedure where a small amount of bone marrow is removed from your hip bone) before you start the medication and at intervals during your treatment. The blood samples are straightforward, but the bone marrow procedures are more involved. Researchers will analyze these samples under a microscope and use special laboratory tests to look for any changes in how your blood cells are developing, comparing your results over time.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Italy